DK1200081T3 - Anvendelse af escitalopram til behandling af generaliseret angstlidelse - Google Patents

Anvendelse af escitalopram til behandling af generaliseret angstlidelse

Info

Publication number
DK1200081T3
DK1200081T3 DK00943692T DK00943692T DK1200081T3 DK 1200081 T3 DK1200081 T3 DK 1200081T3 DK 00943692 T DK00943692 T DK 00943692T DK 00943692 T DK00943692 T DK 00943692T DK 1200081 T3 DK1200081 T3 DK 1200081T3
Authority
DK
Denmark
Prior art keywords
escitalopram
treatment
anxiety disorder
generalized anxiety
generalized
Prior art date
Application number
DK00943692T
Other languages
English (en)
Inventor
Sandra Hogg
Connie Sanchez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8099796&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1200081(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of DK1200081T3 publication Critical patent/DK1200081T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK00943692T 1999-07-08 2000-07-07 Anvendelse af escitalopram til behandling af generaliseret angstlidelse DK1200081T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900991 1999-07-08
PCT/DK2000/000377 WO2001003694A1 (en) 1999-07-08 2000-07-07 Treatment of neurotic disorders

Publications (1)

Publication Number Publication Date
DK1200081T3 true DK1200081T3 (da) 2006-12-27

Family

ID=8099796

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00943692T DK1200081T3 (da) 1999-07-08 2000-07-07 Anvendelse af escitalopram til behandling af generaliseret angstlidelse

Country Status (38)

Country Link
US (6) US7271194B2 (da)
EP (4) EP1440691A3 (da)
JP (1) JP4773011B2 (da)
KR (1) KR100604176B1 (da)
CN (1) CN1198610C (da)
AR (1) AR021155A1 (da)
AT (1) ATE339955T1 (da)
AU (6) AU782514B2 (da)
BG (4) BG110466A (da)
BR (1) BR0011578A (da)
CA (4) CA2687392A1 (da)
CL (3) CL2008003941A1 (da)
CO (1) CO5190674A1 (da)
CY (1) CY1105806T1 (da)
CZ (1) CZ200270A3 (da)
DE (1) DE60030861T2 (da)
DK (1) DK1200081T3 (da)
EA (1) EA006555B1 (da)
ES (1) ES2272298T3 (da)
HK (1) HK1048069B (da)
HR (1) HRP20010820A2 (da)
HU (1) HUP0201791A3 (da)
IL (5) IL146131A0 (da)
IS (1) IS6137A (da)
ME (2) ME00032B (da)
MX (1) MXPA01011626A (da)
MY (1) MY143278A (da)
NO (4) NO329021B1 (da)
PL (1) PL352030A1 (da)
PT (1) PT1200081E (da)
SI (1) SI1200081T1 (da)
SK (1) SK82002A3 (da)
TR (4) TR200402276T2 (da)
TW (1) TWI232101B (da)
UA (1) UA77645C2 (da)
WO (1) WO2001003694A1 (da)
YU (1) YU78701A (da)
ZA (1) ZA200108856B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
BR0113011A (pt) 2000-07-21 2003-07-01 Lundbeck & Co As H Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento
SK14612003A3 (sk) * 2001-05-01 2004-04-06 H. Lundbeck A/S Použitie enantiomérne čistého escitalopramu a farmaceutický prostriedok s obsahom escitalopramu
EP1522539B1 (en) 2001-07-31 2007-01-24 H. Lundbeck A/S Crystalline composition containing escitalopram
AU2003237524A1 (en) * 2002-07-08 2004-01-23 University Of Florida Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
CA2511142A1 (en) * 2002-12-23 2004-07-08 H. Lundbeck A/S Escitalopram hydrobromide and a method for the preparation thereof
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US20090093461A1 (en) * 2003-07-02 2009-04-09 Astrazeneca Ab Methods of Treating Anxiety and Mood Disorders
EP1708790B1 (en) * 2003-12-02 2010-04-21 PharmaNeuroBoost N.V. Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders
US7855195B2 (en) * 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1954257A4 (en) 2005-10-14 2009-05-20 Lundbeck & Co As H METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (da) * 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4439545A (en) 1981-11-19 1984-03-27 Societe D "Expansion Scientifique "Expansia" Acrylic copolymers of N-acryloylpolymethyleneimines or N-acryloyldialkylamides, N,N'-acryloyldiaminoalcanes and N-acryloylaminoacids (or esters) their preparation and use as cation exchangers
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8607313D0 (en) * 1986-03-25 1986-04-30 Ici Plc Pharmaceutical compositions
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US4902710A (en) * 1988-12-14 1990-02-20 Eli Lilly And Company Serotonin and norepinephrine uptake inhibitors
US5114976A (en) * 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
WO1992018005A1 (en) 1991-04-16 1992-10-29 National Institutes Of Health Method of treating trichotillomania and onychophagia
ATE244563T1 (de) 1991-11-15 2003-07-15 Sepracor Inc Verwendung von reinem fluoxetin-s(+)-isomer für die herstellung eines medikements gegen migräne
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
AU4918796A (en) * 1995-02-10 1996-08-27 Eli Lilly And Company Methods of treating or preventing psychiatric disorders
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
ES2145977T3 (es) 1995-08-16 2000-07-16 Lilly Co Eli Potenciacion de la respuesta de la serotonina.
US5846982A (en) * 1996-06-14 1998-12-08 Eli Lilly And Company Inhibition of serotonin reuptake
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5747494A (en) * 1996-06-28 1998-05-05 U C B S.A. Pharmaceutical compositions for the treatment of depressive disorders
US5958429A (en) * 1996-08-16 1999-09-28 Eli Lilly And Company Potentiation of serotonin response
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders
US6069177A (en) * 1997-07-08 2000-05-30 The Hong Kong University Of Science And Technology 3-Hydroxy-propanamine derived neuronal reuptake inhibitors
SE9703375D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
SE9703379D0 (sv) * 1997-09-18 1997-09-18 Astra Ab New compounds
CA2291072C (en) * 1997-11-11 2002-08-20 H. Lundbeck A/S Method for the preparation of citalopram
DK0957099T3 (da) * 1998-04-15 2003-03-17 Pfizer Prod Inc Heterocykliske carboxamider
AU4850199A (en) * 1998-06-30 2000-01-17 Eli Lilly And Company Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
DE69935331T2 (de) 1998-07-13 2007-10-31 NPS Pharmaceuticals, Inc., Salt Lake City Verfahren und verbindungen zur behandlung der depression
US6579899B1 (en) 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
EP1096927A4 (en) 1998-07-16 2002-09-04 Massachusetts Inst Technology STRESS TREATMENT COMPOSITION
US6150376A (en) * 1998-08-05 2000-11-21 Georgetown University Bi- and tri-cyclic aza compounds and their uses
SE9803158D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803157D0 (sv) 1998-09-16 1998-09-16 Astra Ab A new composition
HU228576B1 (en) * 1998-10-20 2013-04-29 Lundbeck & Co As H Method for the preparation of citalopram
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
ATE237604T1 (de) * 1999-04-14 2003-05-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
AU5565401A (en) * 2000-04-24 2001-11-07 Aryx Therapeutics Materials and methods for the treatment of depression
JP2002361405A (ja) * 2000-09-25 2002-12-18 Showa Denko Kk 熱交換器の製造方法
SK14612003A3 (sk) * 2001-05-01 2004-04-06 H. Lundbeck A/S Použitie enantiomérne čistého escitalopramu a farmaceutický prostriedok s obsahom escitalopramu

Also Published As

Publication number Publication date
NO20020062D0 (no) 2002-01-07
KR100604176B1 (ko) 2006-07-25
ATE339955T1 (de) 2006-10-15
NO20100333L (no) 2002-01-07
CA2687392A1 (en) 2001-01-18
TR200200014T2 (tr) 2002-05-21
AU2005202684B2 (en) 2009-01-15
TR200402276T2 (tr) 2005-01-24
NO329021B1 (no) 2010-07-26
EP1440689A2 (en) 2004-07-28
CL2008003941A1 (es) 2009-05-22
IL170193A (en) 2010-04-29
HUP0201791A2 (en) 2002-10-28
BG110466A (en) 2010-01-29
ME00032B (me) 2010-02-10
MEP2508A (xx) 2010-02-10
BG110467A (en) 2010-01-29
EP1440691A3 (en) 2004-08-25
SK82002A3 (en) 2002-07-02
NO20100334L (no) 2002-01-07
TWI232101B (en) 2005-05-11
EP1440690A2 (en) 2004-07-28
US20040029956A1 (en) 2004-02-12
US7265151B2 (en) 2007-09-04
CO5190674A1 (es) 2002-08-29
US20040029957A1 (en) 2004-02-12
AR021155A1 (es) 2002-06-12
NO20020062L (no) 2002-01-07
SI1200081T1 (sl) 2007-02-28
US7271194B2 (en) 2007-09-18
AU2005202685B2 (en) 2009-01-15
TR200402277T2 (tr) 2005-01-24
IL170192A (en) 2010-04-29
CN1198610C (zh) 2005-04-27
JP2003504332A (ja) 2003-02-04
AU2005202686A1 (en) 2005-07-14
AU5806100A (en) 2001-01-30
HK1048069B (zh) 2005-12-16
YU78701A (sh) 2004-03-12
HUP0201791A3 (en) 2005-02-28
CZ200270A3 (cs) 2002-04-17
AU2008264182A1 (en) 2009-01-29
EP1200081B1 (en) 2006-09-20
CN1360501A (zh) 2002-07-24
DE60030861T2 (de) 2007-05-03
AU2005202685A1 (en) 2005-07-14
HK1048069A1 (en) 2003-03-21
US6960613B2 (en) 2005-11-01
EA006555B1 (ru) 2006-02-24
BG110468A (en) 2010-01-29
US20070276035A1 (en) 2007-11-29
DE60030861D1 (de) 2006-11-02
PT1200081E (pt) 2007-01-31
EP1440690A3 (en) 2004-08-18
UA77645C2 (en) 2007-01-15
US20040029958A1 (en) 2004-02-12
TR200402275T2 (tr) 2005-03-21
US20020086899A1 (en) 2002-07-04
EP1200081A1 (en) 2002-05-02
EP1440689A3 (en) 2004-08-25
AU782514B2 (en) 2005-08-04
CA2373757C (en) 2010-01-05
IL170194A (en) 2010-05-31
NO20100335L (no) 2002-01-07
ES2272298T3 (es) 2007-05-01
KR20020015346A (ko) 2002-02-27
CL2008003938A1 (es) 2009-05-22
IL146131A (en) 2007-02-11
CA2687394A1 (en) 2001-01-18
WO2001003694A1 (en) 2001-01-18
IS6137A (is) 2001-10-30
CA2373757A1 (en) 2001-01-18
US20050101665A1 (en) 2005-05-12
AU2008264188A1 (en) 2009-05-07
BG106279A (bg) 2002-08-30
CL2008003939A1 (es) 2009-06-05
MY143278A (en) 2011-04-15
EA200200137A1 (ru) 2002-06-27
JP4773011B2 (ja) 2011-09-14
MXPA01011626A (es) 2002-06-04
HRP20010820A2 (en) 2003-08-31
AU2005202686B2 (en) 2009-01-15
ZA200108856B (en) 2002-12-24
IL146131A0 (en) 2002-07-25
PL352030A1 (en) 2003-07-28
CY1105806T1 (el) 2011-02-02
CA2687396A1 (en) 2001-01-18
AU2005202684A1 (en) 2005-07-14
EP1440691A2 (en) 2004-07-28
BR0011578A (pt) 2002-03-26

Similar Documents

Publication Publication Date Title
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1223927T3 (da) Anvendelse af retigabin til behandling af neuropatiske smerter
DK1200081T3 (da) Anvendelse af escitalopram til behandling af generaliseret angstlidelse
DK1176195T3 (da) Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle
DK1173431T4 (da) Fremgangsmåde til fremstilling af citalopram
DK1147114T3 (da) Hidtil ukendt aralkylaminer af spirofuropyridiner, der er egnede til terapi
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1231920T3 (da) Anvendelse af epinastin til behandling af allergisk rhinitis/conjunctivitis
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
DK1206436T3 (da) Retinoider til behandling af emfysem
DK199800837A (da) Anlæg til behandling af emner
DK0965566T3 (da) Fremgangsmåde til behandling af organisk spildevand
DK1458386T3 (da) Aroylpyrrolheteroaryl- og methanolforbindelser til behandling af en lidelse i centralnervesystemet
DK1197485T3 (da) Cyclobutendionderivater til behandling af artherosclerose
DK1008558T3 (da) Fremgangsmåde til behandling af organisk spildevand
DK3103443T3 (da) Fremgangsmåde til behandling af primær søvnforstyrrelse
DK0928183T3 (da) Anvendelse af 1-hydroxy-2-pyridoner til behandling af seborrhoisk dermatitis
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser